Related Experiment Videos
'It's too late'. Is it really? Considerations for amblyopia treatment in older children
Marianne E F Piano1, Anita J Simmers2
1School of Health Sciences, University of Surrey, Guildford, UK.
Insights
It is not too late to treat amblyopia, commonly known as lazy eye, in children aged 7 and older. Evidence shows conventional treatments can still improve vision in older children with amblyopia.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Vision Science
Background:
- Community eyecare services sometimes incorrectly inform families that amblyopia (lazy eye) treatment is ineffective for children over 7.
- Current professional guidance emphasizes early diagnosis but lacks age-specific parameters for treating strabismus and amblyopia.
- Recent literature and clinical practice demonstrate that conventional amblyopia treatments can be effective in older children.
Purpose of the Study:
- To address misconceptions about the age limit for amblyopia treatment.
- To review current considerations and evidence for treating amblyopia in children aged 7 and older.
- To highlight recent advances in amblyopia treatment for this age group.
Main Methods:
- This is a perspective review, synthesizing existing literature and clinical evidence.
- The review examines risks, benefits, and efficacy of treating newly diagnosed amblyopia in older children.
- It also considers advancements in binocular treatments and strategies for managing suppression.
Main Results:
- Conventional amblyopia treatments (occlusion, atropine penalisation) can improve visual acuity in children over 7 years old.
- Effective treatment requires careful consideration of risks, benefits, and individual patient factors.
- Monitoring suppression is crucial to minimize the risk of intractable diplopia.
Conclusions:
- Age is not an absolute barrier to successful amblyopia treatment.
- Clinicians should be aware of the evidence supporting treatment for older children and address parental concerns.
- Further research into novel and binocular treatments may enhance outcomes for older amblyopic patients.
Abstract:
In recent years, media coverage has demonstrated instances in which families of children aged 7 and older, newly diagnosed with strabismic and/or anisometropic amblyopia through community eyecare services, were told it was 'too late' for their child to effectively respond to conventional amblyopia treatment (occlusion or atropine penalisation). Formal guidance pertaining to binocular vision anomalies from eyecare professional bodies does not specifically make reference to a child's age, beyond stating the importance of early diagnosis and treatment of strabismus/amblyopia. However, there have been many changes in the way we view the recovery period for amblyopia, and it is well demonstrated both within literature and clinical practice that conventional treatment can improve amblyopic eye visual acuity in children beyond the age of 7 years. The occurrence of these media described cases within the community eyecare sphere would suggest it is worthwhile revisiting the literature on the subject of amblyopia treatment in older children (aged 7+ years), to address misconceptions and place in the spotlight current considerations facing clinicians when treating newly diagnosed amblyopia within this age group. This perspective review provides an evidence-based update covering the various considerations associated with treatment of amblyopia in older children, along with recent amblyopia treatment advances that could have an impact on treatment prospects for this patient group. Considerations include the risks, benefits and efficacy of treating newly diagnosed amblyopia in older children, monitoring density of suppression to mitigate intractable diplopia risk, and recent findings regarding binocular treatments for amblyopia.